Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

NCT07066982 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Sarcoma, Kaposi
Sarcoma, Ewing
Sarcoma,Soft Tissue
Sarcoma of Bone and Connective Tissue
Sarcoma, Synovial
Sarcoma Metastatic
Sarcomas, Germinoblastic
Sarcoma of Bone

Interventions

BIOLOGICAL: CD146/HER2 CAR-T cells

Sponsor

Essen Biotech